These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
605 related articles for article (PubMed ID: 8866039)
1. In vivo/in vitro correlations for four differently dissolving ketorolac tablets. Gordon MS; Chowhan Z Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039 [TBL] [Abstract][Full Text] [Related]
2. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
3. Formulation and pharmacokinetics of ketorolac tromethamine fast dissolving tablets. Mettu SR; Veerareddy PR Drug Res (Stuttg); 2013 Nov; 63(11):586-90. PubMed ID: 23780501 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations. Rekhi GS; Eddington ND; Fossler MJ; Schwartz P; Lesko LJ; Augsburger LL Pharm Dev Technol; 1997 Feb; 2(1):11-24. PubMed ID: 9552427 [TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo correlation for two gliclazide extended-release tablets. Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin. Ahmed IS; Aboul-Einien MH Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characteristics of some commercial phenobarbital tablets. Sylvestri MF; Ueda CT Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):492-7. PubMed ID: 528095 [TBL] [Abstract][Full Text] [Related]
8. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials. Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
10. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets. Ammar HO; Khalil RM; Omar SM Pharmazie; 1993 Dec; 48(12):932-5. PubMed ID: 8115438 [TBL] [Abstract][Full Text] [Related]
11. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability. Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers. Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765 [TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet. Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381 [TBL] [Abstract][Full Text] [Related]
14. Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism. Volpato NM; Silva RL; Brito AP; Gonçalves JC; Vaisman M; Noël F Eur J Pharm Sci; 2004 Apr; 21(5):655-60. PubMed ID: 15066666 [TBL] [Abstract][Full Text] [Related]
15. [Studies on formulation and bioavailability of benorilate tablets]. Chen J; Tu XD Yao Xue Xue Bao; 1994; 29(9):707-12. PubMed ID: 7900541 [TBL] [Abstract][Full Text] [Related]
16. Formulation of a extended release tablet containing dexibuprofen. Yi HG; Chi MH; Kim YI; Woo JS; Park ES Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235 [TBL] [Abstract][Full Text] [Related]
17. Comparative bioavailability study of two oral formulations of ibuprofen. Corpetti G; Rosignoli MT; Dionisio P Arzneimittelforschung; 1998 Apr; 48(4):392-5. PubMed ID: 9608882 [TBL] [Abstract][Full Text] [Related]
18. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits. Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994 [TBL] [Abstract][Full Text] [Related]
19. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568 [TBL] [Abstract][Full Text] [Related]
20. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]